Body Composition Changes in Children Living With HIV Initiated on Dolutegravir or Protease Inhibitors in the CHAPAS-4 Trial. Natukunda E, Szubert AJ, Bwakura-Dangarembizi M, Mulenga V, et al. Pediatr Infect Dis J 2026 Feb 24. doi: 10.1097/INF.0000000000005195.

Read + Share

Amedeo Smart

Independent Medical Education

Natukunda E, Szubert AJ, Bwakura-Dangarembizi M, Mulenga V, et al. Body Composition Changes in Children Living With HIV Initiated on Dolutegravir or Protease Inhibitors in the CHAPAS-4 Trial. Pediatr Infect Dis J 2026 Feb 24. doi: 10.1097/INF.0000000000005195.
PMID: 41731659